Skip to content

Clinical trials

Epstein-Barr Virus Infections trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Epstein-Barr Virus Infections Country / region: Australia Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20141
20172
20211
20221
20241
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated4
Active, not recruiting2
Recruiting2
Completed1
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Atara Biotherapeutics2
AlloVir1
ModernaTX, Inc.1
NRG Oncology1
Pierre Fabre Medicament1
Queensland Institute of Medical Research1
Sanofi Pasteur, a Sanofi Company1
Vaccine Company, Inc.1
Viracta Therapeutics, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Epstein-Barr Virus Infections10
Adenoviridae Infections1
Autoimmune Diseases1
Cytomegalovirus Infections1
Demyelinating Diseases1
Inflammation1
Lymphoma1
Lymphoma, B-Cell1
Lymphoma, Follicular1
Lymphoma, Large B-Cell, Diffuse1

Trials

Showing 76 to 10 of 10. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.